The University of Sheffield
Health Services Research

Dr James Fotheringham MBChB MRCP

James Fotheringham

Postgraduate Research Student

Addresses

School of Health and Related Research (ScHARR)
The University of Sheffield
Regent Court, 30 Regent Street
Sheffield
S1 4DA

Sheffield Kidney Institute
Northern General Hospital
Herries Road
Sheffield
S5 7AU

Tel: +44 (0)114 2714410

Email: james.fotheringham@sheffield.ac.uk

Biography

I trained in Medicine in Sheffield graduating in 2003, and soon realised my interest in Renal Medicine.

During my training in this speciality I became interested in epidemiology and quality measurement, specifically using routinely collected or existing data. This culminated in my PhD with ScHARR starting in 2010.

Combining the national registry of patients receiving dialysis for established renal disease with the record of hospitalisation in English hospitals, I plan to understand factors influencing hospitalisation and mortality in this complex patient group.

Research Interests

I plan to continue this work following my PhD to develop strategies for real-time monitoring of outcomes, novel methods of collecting end-points for clinical trials and performing power calculations.

Teaching Interests

I teach on the subject of Renal Transplantation on the Certificate for Long Term Conditions run by the University of Sheffield.

Professional Activities

I report to the UK Renal Registry on my research with their data, and continue clinical activity in a reduced capacity.

Current Projects

Measuring quality and driving change in renal services using routinely collected data: The combination if incident renal replacement therapy patients (2002 – 2006, n=22,418) with the Hospital Episode Statistics database (1998 – date) to measure quality and explore epidemiology.

Statistical Appraisal of the Standardised Hospital Mortality Index Report.

James is funded by a Kidney Research UK Clinical Training Fellowship

Supervisors

Professor Mike Campbell and Professor Meguid El Nahas.

Key Publications

  1. Post-Parathyroidectomy Parathyroid Hormone Levels: The Impact on Patient Survival – A Single-Centre Study in a Stage 5 Chronic Kidney Disease Population. James Fotheringham, Saba P. Balasubramanian, Barney Harrison, Martin Wilkie. Nephron Clin Pract 2011;119:c113-c120 (DOI: 10.1159/000326683).
  2. Natural history of proteinuria in renal transplant recipients developing de novo human leukocyte antigen antibodies. Fotheringham J, Angel C, Goodwin J, Harmer AW, McKane WS. Transplantation. 2011 May 15;91(9):991-6.
  3. Can HLA Specific Antibody Tests Predict Rejection? Oral Communication – British Transplant Society Meeting March 2011.
  4. Assessing The Cost Of Parathyroidectomy As A Treatment For Uncontrolled Secondary Hyperparathyroidism In Stage 5 Chronic Kidney Disease – Poster - European Renal Association June 2010.
  5. A Multi-Targeted Regime Reduces Bacteraemia in Patients Receiving Hemodialysis Via a Tunnelled Central Venous Catheter – Poster -American Society of Nephrology Renal Week Nov 2009.
  6. Transplant glomerulopathy: morphology, associations and mechanism. Fotheringham J, Angel CA, McKane W. Nephron Clin Pract. 2009;113(1):c1-7; discussion c7. Epub 2009 Jul 10.
  7. The utility and cost of the British Transplant Society guidance on screening HLA antibodies in the first year after renal transplantation – Oral Communication - Renal Association & British Transplant Society Annual Congress April 2009.
  8. The Impact on Survival of the Recovery of Intact PTH Levels Following Parathyroidectomy in a Single Centre Stage V Chronic Kidney Disease Population - Oral Communication - Renal Association & British Transplant Society Annual Congress April 2009.
  9. Proteinuria Precedes Donor Specific Antibody after Kidney Transplantation – Oral Communication – American Society of Nephrology Renal Week Nov 2007.


Section

James is based in Health Services Research.